OSE Immunotherapeutics SA (EPA:OSE)
3.024
-0.050 (-1.63%)
Apr 24, 2026, 5:35 PM CET
Revenue by Segment
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Source: S&P Global Market Intelligence.